By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Fosphenytoin sodium injection, USP, can be used to treat and prevent seizures during neurosurgery as well as to control generalized convulsive status epilepticus.
It can also be used in place of oral phenytoin for short periods of time. 1.5 mg of fosphenytoin sodium, or “1 mg phenytoin sodium equivalents,” is the same as 1 mg of phenytoin sodium.
Fosphenytoin concentration and quantity are always expressed in mg PE.A 1,000-mg PE dose of fosphenytoin is equivalent to a 1,000-mg dose of phenytoin, or fosphenytoin 15 to 20 mg PE/kg is equivalent to phenytoin 15 to 20 mg/kg.
Fosphenytoin should not be given faster than 150 mg PE/min due to the risk of severe hypotension and cardiac arrhythmias;examine THE Monitoring, Precautions, and Administration Rate.
The Global Fosphenytoin sodium injection market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
An abbreviated new drug application (ANDA) for fosphenytoin sodium injection USP, 100 mg/2mL and 500 mg/10mL (equivalent to phenytoin sodium), has been approved by the FDA in the United States.
A prodrug of phenytoin sodium called fosphenytoin sodium injection is approved for short-term use to prevent and control generalized seizures that occur during neurosurgery.
Parenterally, the drug metabolizes into the active metabolite phenytoin sodium as a prodrug.
Akorn, Inc. and Strides Arcolab jointly fund the manufacturing of this drug’s variant.The US-based company Acorn makes and sells sterile specialty pharmaceuticals.
One of the largest exporters of brand-name generic pharmaceuticals from India, Strides Arcolab Ltd has manufacturing facilities in the United States, Brazil, Mexico, Italy, Poland, Singapore, and India.
Additionally, the portfolio of the joint venture includes 53 product line offerings and 29 ANDAs.